CORR Insights®: High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
作者信息
Ghert Michelle
机构信息
M. Ghert, Associate Professor, McMaster University and Hamilton Health Sciences, Department of Surgery, Hamilton, Ontario, Canada.
出版信息
Clin Orthop Relat Res. 2019 Jul;477(7):1687-1688. doi: 10.1097/CORR.0000000000000777.
Abstract
摘要
相似文献
1
CORR Insights®: High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
Clin Orthop Relat Res. 2019 Jul;477(7):1687-1688. doi: 10.1097/CORR.0000000000000777.
2
High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
Clin Orthop Relat Res. 2019 Jul;477(7):1674-1686. doi: 10.1097/CORR.0000000000000733.
3
High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
Clin Orthop Relat Res. 2018 Oct;476(10):2052-2061. doi: 10.1097/CORR.0000000000000463.
4
The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients.
J Neurosurg Spine. 2018 Jan;28(1):88-95. doi: 10.3171/2017.5.SPINE161399. Epub 2017 Nov 10.
5
Incidence of symptomatic venous thromboembolism after elective knee arthroscopy.
J Bone Joint Surg Am. 2012 Apr 18;94(8):714-20. doi: 10.2106/JBJS.J.01759.
6
Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
J Neurosurg Spine. 2014 Oct;21(4):677-84. doi: 10.3171/2014.6.SPINE13447. Epub 2014 Aug 8.
7
Incidence and Risk Factors for Venous Thromboembolism After Spine Surgery in Korean Patients.
World Neurosurg. 2019 Aug;128:e289-e307. doi: 10.1016/j.wneu.2019.04.140. Epub 2019 Apr 25.
8
Incidence of venous thromboembolism after spine surgery.
J Orthop Sci. 2012 Mar;17(2):114-7. doi: 10.1007/s00776-011-0188-2. Epub 2012 Jan 6.
9
[Incidence and risk factors of venous thromboembolism in major spinal surgery with no chemical or mechanical prophylaxis].
Rev Esp Cir Ortop Traumatol. 2016 Mar-Apr;60(2):133-40. doi: 10.1016/j.recot.2015.10.002. Epub 2016 Jan 13.
10
Incidence of symptomatic venous thromboembolism in oncologic patients undergoing lower-extremity endoprosthetic arthroplasty.
J Bone Joint Surg Am. 2011 May 4;93(9):847-54. doi: 10.2106/JBJS.H.01640.
本文引用的文献
1
High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
Clin Orthop Relat Res. 2019 Jul;477(7):1674-1686. doi: 10.1097/CORR.0000000000000733.
2
Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
Gynecol Oncol. 2019 Feb;152(2):286-292. doi: 10.1016/j.ygyno.2018.11.021. Epub 2018 Nov 22.
3
New anticoagulants, reversal agents, and clinical considerations for perioperative practice.
Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):165-178. doi: 10.1016/j.bpa.2018.06.008. Epub 2018 Jul 3.
4
Anticoagulation for perioperative thromboprophylaxis in people with cancer.
Cochrane Database Syst Rev. 2018 Jul 11;7(7):CD009447. doi: 10.1002/14651858.CD009447.pub3.
5
Complications and reoperations after surgery for 647 patients with spine metastatic disease.
Spine J. 2019 Jan;19(1):144-156. doi: 10.1016/j.spinee.2018.05.037. Epub 2018 Jun 1.
6
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.
Thromb Res. 2019 Jan;173:158-163. doi: 10.1016/j.thromres.2018.02.144. Epub 2018 Mar 2.
7
Cancer treatment and survivorship statistics, 2016.
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.
8
Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
Sci Rep. 2016 Mar 29;6:23726. doi: 10.1038/srep23726.
9
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
Ann Intern Med. 2013 Aug 20;159(4):275-84. doi: 10.7326/0003-4819-159-4-201308200-00008.
10
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.
BMJ. 2012 Jun 14;344:e3675. doi: 10.1136/bmj.e3675.
Zotero 插件